| [1] |
Dumas G, Arabi YM, Bartz R, et al. Diagnosis and management of autoimmune diseases in the ICU [J]. Intensive Care Med, 2024, 50(1)：17-35.
|
| [2] |
Merighi A, Lossi L. Endoplasmic reticulum stress signaling and neuronal cell death [J]. Int J Mol Sci, 2022, 23(23): 15186.
|
| [3] |
Sano R, Reed JC. ER stress-induced cell death mechanisms [J]. Biochim Biophys Acta, 2013, 1833(12): 3460-3470.
|
| [4] |
Szegezdi E, Logue SE, Gorman AM, et al. Mediators of endoplasmic reticulum stress-induced apoptosis [J]. EMBO Rep, 2006, 7(9): 880-885.
|
| [5] |
Tabas I, Ron D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress [J]. Nat Cell Biol, 2011, 13(3): 184-190.
|
| [6] |
Chen S, Chen J, Hua X, et al. The emerging role of XBP1 in cancer [J]. Biomed Pharmacother, 2020, 127: 110069.
|
| [7] |
Garg AD, Kaczmarek A, Krysko O, et al. ER stress-induced inflammation: Does it aid or impede disease progression? [J]. Trends Mol Med, 2012, 18(10): 589-598.
|
| [8] |
Xu G, Liu K, Anderson J, et al. Expression of XBP1s in bone marrow stromal cells is critical for myeloma cell growth and osteoclast formation [J]. Blood, 2012, 119(18): 4205-4214.
|
| [9] |
Bettigole SE, Glimcher LH. Endoplasmic reticulum stress in immunity [J]. Annu Rev Immunol, 2015, 33(1): 107-138.
|
| [10] |
So JS. Roles of endoplasmic reticulum stress in immune responses [J]. Mol Cells, 2018, 41(8): 705-716.
|
| [11] |
Iwakoshi NN, Lee AH, Vallabhajosyula P, et al. Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1 [J]. Nat Immunol, 2003, 4(4): 321-329.
|
| [12] |
Park SM, Kang TI, So JS. Roles of XBP1s in transcriptional regulation of target genes [J]. Biomedicines, 2021, 9(7): 791.
|
| [13] |
Gass JN, Gifford NM, Brewer JW. Activation of an unfolded protein response during differentiation of antibody-secreting B cells [J]. J Biol Chem, 2002, 277(50): 49047-49054.
|
| [14] |
Brucklacher-Waldert V, Ferreira C, Stebegg M, et al. Cellular stress in the context of an inflammatory environment supports TGF-β-independent T helper-17 differentiation [J]. Cell Rep, 2017, 19(11): 2357-2370.
|
| [15] |
Stadhouders R, Lubberts E, Hendriks RW. A cellular and molecular view of T helper 17 cell plasticity in autoimmunity [J]. J Autoimmun, 2018, 87: 1-15.
|
| [16] |
Pramanik J, Chen X, Kar G, et al. Genome-wide analyses reveal the IRE1a-XBP1 pathway promotes T helper cell differentiation by resolving secretory stress and accelerating proliferation [J]. Genome Med, 2018, 10(1): 76.
|
| [17] |
Xiao D, Li S, Gui B, et al. Effect of uremic serum on Th17/Treg cell balance and endoplasmic reticulum stress in rats [J]. Biomed Pharmacother, 2020, 131: 110705.
|
| [18] |
Ang Z, Er JZ, Ding JL. The short-chain fatty acid receptor GPR43 is transcriptionally regulated by XBP1 in human monocytes [J]. Sci Rep, 2015, 5(1): 8134.
|
| [19] |
Martinon F, Chen X, Lee AH, et al. TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages [J]. Nat Immunol, 2010, 11(5): 411-418.
|
| [20] |
Bettigole SE, Lis R, Adoro S, et al. The transcription factor XBP1 is selectively required for eosinophil differentiation [J]. Nat Immunol, 2015, 16(8): 829-837.
|
| [21] |
Iwakoshi NN, Pypaert M, Glimcher LH. The transcription factor XBP-1 is essential for the development and survival of dendritic cells [J]. J Exp Med, 2007, 204(10): 2267-2275.
|
| [22] |
Hu F, Yu X, Wang H, et al. ER stress and its regulator X-box-binding protein-1 enhance polyIC-induced innate immune response in dendritic cells [J]. Eur J Immunol, 2011, 41(4): 1086-1097.
|
| [23] |
Cubillos-Ruiz JR, Silberman PC, Rutkowski MR, et al. ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis [J]. Cell, 2015, 161(7): 1527-1538.
|
| [24] |
Lipsky PE. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity [J]. Nat Immunol, 2001, 2(9): 764-766.
|
| [25] |
Iwata S, Tanaka Y. B-cell subsets, signaling and their roles in secretion of autoantibodies [J]. Lupus, 2016, 25(8): 850-856.
|
| [26] |
Xiang L, Liu A, Xu G. Expression of XBP1s in B lymphocytes is critical for pristane-induced lupus nephritis in mice [J]. Am J Physiol Renal Physiol, 2020, 318(5): F1258-F1270.
|
| [27] |
Yap D, Lai K. Pathogenesis of renal disease in systemic lupus erythematosus--the role of autoantibodies and lymphocytes subset abnormalities [J]. Int J Mol Sci, 2015, 16(4): 7917-7931.
|
| [28] |
Yap DYH, Chan TM. B cell abnormalities in systemic lupus erythematosus and lupus nephritis-role in pathogenesis and effect of immunosuppressive treatments [J]. Int J Mol Sci, 2019, 20(24): 6231.
|
| [29] |
De Luca F, Shoenfeld Y. The microbiome in autoimmune diseases [J]. Clin Exp Immunol, 2019, 195(1): 74-85.
|
| [30] |
Navid F, Colbert RA. Causes and consequences of endoplasmic reticulum stress in rheumatic disease [J]. Nat Rev Rheumatol, 2016, 13(1): 25-40.
|
| [31] |
Savic S, Ouboussad L, Dickie LJ, et al. TLR dependent XBP-1 activation induces an autocrine loop in rheumatoid arthritis synoviocytes [J]. J Autoimmun, 2014, 50(100): 59-66.
|
| [32] |
Corrigall VM, Bodman-Smith MD, Brunst M, et al. Inhibition of antigen-presenting cell function and stimulation of human peripheral blood mononuclear cells to express an antiinflammatory cytokine profile by the stress protein BiP: relevance to the treatment of inflammatory arthritis [J]. Arthritis Rheum, 2004, 50(4): 1164-1171.
|
| [33] |
Hu F, Tang Y, Wang P, et al. Endoplasmic reticulum stress perpetuated Toll-like receptor signalling-mediated inflammation in rheumatoid arthritis via X-box-binding protein-1 [J]. Clin Exp Rheumatol, 2021, 39(4): 859-867.
|
| [34] |
Piperi C, Adamopoulos C, Papavassiliou AG. XBP1: a pivotal transcriptional regulator of glucose and lipid metabolism [J]. Trends Endocrinol Metab, 2016, 27(3): 119-122.
|
| [35] |
Volkmann K, Lucas JL, Vuga D, et al. Potent and selective inhibitors of the inositol-requiring enzyme 1 endoribonuclease [J]. J Biol Chem, 2011, 286(14): 12743-12755.
|
| [36] |
Cross BCS, Bond PJ, Sadowski PG, et al. The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule [J]. Proc Natl Acad Sci, 2012, 109(15): E869-E878.
|
| [37] |
Mimura N, Fulciniti M, Gorgun G, et al. Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma [J]. Blood, 2012, 119(24): 5772-5781.
|
| [38] |
Papandreou I, Denko NC, Olson M, et al. Identification of an IRE1α endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma [J]. Blood, 2011, 117(4): 1311-1314.
|
| [39] |
Ri M, Tashiro E, Oikawa D, et al. Identification of toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing [J]. Blood Cancer J, 2012, 2(7): e79.
|
| [40] |
Sanches M, Duffy NM, Talukdar M, et al. Structure and mechanism of action of the hydroxy-aryl-aldehyde class of IRE1 endoribonuclease inhibitors [J]. Nat Commun, 2014, 5(1): 4202.
|
| [41] |
Wang L, Perera BGK, Hari SB, et al. Divergent allosteric control of the IRE1α endoribonuclease using kinase inhibitors [J]. Nat Chem Biol, 2012, 8(12): 982-989.
|
| [42] |
Ji L, Hou X, Deng X, et al. Jieduquyuziyin prescription-treated rat serum suppresses activation of peritoneal macrophages in MRL/lpr lupus mice by inhibiting IRAK1 signaling pathway [J]. Evid Based Complement Alternat Med, 2019, 2019: 2357217.
|
| [43] |
Wiseman RL, Zhang Y, Lee KPK, et al. Flavonol activation defines an unanticipated ligand-binding site in the kinase-RNase domain of IRE1 [J]. Mol Cell, 2010, 38(2): 291-304.
|
| [44] |
Zhou Z, Li A, Wang Z, et al. Blimp-1 siRNA inhibits B cell differentiation and prevents the development of lupus in mice [J]. Hum Immunol, 2013, 74(3): 297-301.
|
| [45] |
Chen X, Iliopoulos D, Zhang Q, et al. XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway [J]. Nature, 2014, 508(7494): 103-107.
|
| [46] |
Leung-Hagesteijn C, Erdmann N, Cheung G, et al. XBP1s-negative tumor B cells and pre-plasmablasts mediate therapeutic proteasome inhibitor resistance in multiple myeloma [J]. Cancer Cell, 2013, 24(3): 289-304.
|
| [47] |
Mei Y, Wang X. RNA modification in mRNA cancer vaccines [J]. Clin Exp Med, 2023, 23(6): 1917-1931.
|